AzTrials
AzTrials

InjuryI-ReductAINCT06805162

Effect of an Unsupervised Multi-domain Intervention on Injury Risk Reduction in Athletics (I-ReductAI).

A study testing Normal training and Specific training in people with Injury, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

In athletics, injuries can affect athletes' participation in athletics, their performance and career, but also their health in physical, psychological and social aspects, in the short, medium and long term. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Injury
What is being tested?
Normal training and Specific training
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
643 participants
Where
1 siteFrance
Study dates
7 Feb 2025to 21 Jul 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • be licensed at the French Athletics Federation (FFA) for competition (sprints, hurdles, jumps, throws, combined events, and endurance disciplines), without any counter-indications for competitive athletics activity attested by the license at the FFA;
  • have daily access to a digital device (smartphone, computer, tablet) with a network connection (public or private).

Who cannot join

  • Any athlete deprived of liberty or subject to legal protection (guardianship, under curatorship, legal protection).

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalier Universitaire

    Saint-Etienne, 42055

Other trials in France

About this study

Official title: Effect of an Unsupervised Multi-domain Intervention on Injury Risk Reduction in Athletics: Protocol of a Randomized Controlled Trial

In athletics, injuries can affect athletes' participation in athletics, their performance and career, but also their health in physical, psychological and social aspects, in the short, medium and long term.

Read the detailed description

This justifies the development and implementation of injury risk reduction strategies. These should be developed according to a holistic approach that considers the complex aetiology of injuries in sport. Although many different injury risk reduction strategies have been studied in sport, in general, each has been evaluated in isolation, including for example education, neuromuscular exercises, psychological techniques or individual injury risk assessment. The investigators therefore hypothesized that their combination could improve the overall effectiveness of an intervention aimed at reducing the risk of injuries in athletics.

Conditions
Injury
Being tested
Normal training, Specific training
Keywords
NEURO MUSCULAR, Athletics, injury prevention
Medical subject headings
Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Normal trainingOther

    Athletes should continue their normal training

  • Specific trainingOther

    Athletes should consider i) watching the educational videos on injury prevention, ii) perform the neuro-muscular exercises, iii) practice the techniques against stress and anxiety, and iv) consider the injury prognostic feedback.

Study groups in NCT06805162
Study groupRoleWhat they receive
Specific trainingExperimentalthere will be a multi-domain intervention: i) A series of 12 educational videos on injury prevention; ii) Neuro-muscular exercise-based injury prevention programmes; iii) Techniques against stress and anxiety through breathing and mindfulness practice; iv) Injury prognostic feedback using individual data and based on a machine learning model.
Receives: Other: Specific training
Normal trainingActive comparatorAthletes who continue their normal training
Receives: Other: Normal training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time (day) until the first Injury-type Complaint related to athletics and resulting in Restricted Participation in athletics (ICRP)

    Time in days during which athletes are free of ICRP, between an intervention group and a control group

    Measured: Week 14

Secondary outcomes (4)
  1. Number of ICRP per 1000 hours of athletics practice

    The number of ICRP per 1000 hours of athletics practice during a summer athletics competition season (14 weeks)

    Measured: Week 14

  2. Number of days with an ICRP per 1000 hours of athletics practice

    Number of days with ICRP per 1000 hours of athletics practice) during a summer athletics competition season (14 weeks)

    Measured: Week 14

  3. Percentage of athletes with at least one ICRP

    The percentage of athletes with at least one ICRP during a summer athletics competition season (14 weeks)

    Measured: Week 14

  4. The average percentage of athletes with at least one ICRP

    The average percentage of athletes with at least one ICRP per week during a summer athletics competition season (14 weeks)

    Measured: Week 14

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2025
  2. Study start7 Feb 2025
  3. Primary completion21 Jul 2025 (estimated)
  4. Study completion21 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
643 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06805162
Sponsor's protocol ID
24CH262
Acronym
I-ReductAI
Status last verified
Feb 2025
First submitted
28 Jan 2025
Last updated
29 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Normal training and Specific training in people with Injury, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 29 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time (day) until the first Injury-type Complaint related to athletics and resulting in Restricted Participation in athletics (ICRP) (time frame: Week 14). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in